DEI Quote, Financials, Valuation and Earnings

Omega Healthcare Investors, Inc. has a net margin of -7.92% compared to Douglas Emmett, Inc.'s net margin of 53.44%. Douglas Emmett, Inc.'s return on equity of -0.35% beat Omega Healthcare Investors, Inc.'s return on equity of 11.93%.

Douglas Emmett, Inc. has a consensus price target of $13.05, signalling upside risk potential of 27.07%. On the other hand Omega Healthcare Investors, Inc. has an analysts' consensus of $48.06 which suggests that it could grow by 2.74%. Given that Douglas Emmett, Inc. has higher upside potential than Omega Healthcare Investors, Inc., analysts believe Douglas Emmett, Inc. is more attractive than Omega Healthcare Investors, Inc..

Douglas Emmett, Inc. has a beta of 1.139, which suggesting that the stock is 13.908% more volatile than S&P 500. In comparison Omega Healthcare Investors, Inc. has a beta of 0.567, suggesting its less volatile than the S&P 500 by 43.268%.

Douglas Emmett, Inc. has a quarterly dividend of $0.19 per share corresponding to a yield of 7.4%. Omega Healthcare Investors, Inc. offers a yield of 5.73% to investors and pays a quarterly dividend of $0.67 per share. Douglas Emmett, Inc. pays 781.89% of its earnings as a dividend. Omega Healthcare Investors, Inc. pays out 138.19% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Douglas Emmett, Inc. quarterly revenues are $249.4M, which are smaller than Omega Healthcare Investors, Inc. quarterly revenues of $321.8M. Douglas Emmett, Inc.'s net income of -$19.8M is lower than Omega Healthcare Investors, Inc.'s net income of $172M. Notably, Douglas Emmett, Inc.'s price-to-earnings ratio is 113.48x while Omega Healthcare Investors, Inc.'s PE ratio is 24.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Douglas Emmett, Inc. is 1.71x versus 11.90x for Omega Healthcare Investors, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Prologis, Inc. has a net margin of -7.92% compared to Douglas Emmett, Inc.'s net margin of 65.8%. Douglas Emmett, Inc.'s return on equity of -0.35% beat Prologis, Inc.'s return on equity of 5.93%.

Douglas Emmett, Inc. has a consensus price target of $13.05, signalling upside risk potential of 27.07%. On the other hand Prologis, Inc. has an analysts' consensus of $139.40 which suggests that it could fall by -0.34%. Given that Douglas Emmett, Inc. has higher upside potential than Prologis, Inc., analysts believe Douglas Emmett, Inc. is more attractive than Prologis, Inc..

Douglas Emmett, Inc. has a beta of 1.139, which suggesting that the stock is 13.908% more volatile than S&P 500. In comparison Prologis, Inc. has a beta of 1.419, suggesting its more volatile than the S&P 500 by 41.87%.

Douglas Emmett, Inc. has a quarterly dividend of $0.19 per share corresponding to a yield of 7.4%. Prologis, Inc. offers a yield of 2.89% to investors and pays a quarterly dividend of $1.01 per share. Douglas Emmett, Inc. pays 781.89% of its earnings as a dividend. Prologis, Inc. pays out 113.56% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Douglas Emmett, Inc. quarterly revenues are $249.4M, which are smaller than Prologis, Inc. quarterly revenues of $2.3B. Douglas Emmett, Inc.'s net income of -$19.8M is lower than Prologis, Inc.'s net income of $1.5B. Notably, Douglas Emmett, Inc.'s price-to-earnings ratio is 113.48x while Prologis, Inc.'s PE ratio is 39.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Douglas Emmett, Inc. is 1.71x versus 15.22x for Prologis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

SL Green Realty Corp. has a net margin of -7.92% compared to Douglas Emmett, Inc.'s net margin of -37.52%. Douglas Emmett, Inc.'s return on equity of -0.35% beat SL Green Realty Corp.'s return on equity of -2.22%.

Douglas Emmett, Inc. has a consensus price target of $13.05, signalling upside risk potential of 27.07%. On the other hand SL Green Realty Corp. has an analysts' consensus of $51.83 which suggests that it could grow by 28.02%. Given that SL Green Realty Corp. has higher upside potential than Douglas Emmett, Inc., analysts believe SL Green Realty Corp. is more attractive than Douglas Emmett, Inc..

Douglas Emmett, Inc. has a beta of 1.139, which suggesting that the stock is 13.908% more volatile than S&P 500. In comparison SL Green Realty Corp. has a beta of 1.622, suggesting its more volatile than the S&P 500 by 62.19%.

Douglas Emmett, Inc. has a quarterly dividend of $0.19 per share corresponding to a yield of 7.4%. SL Green Realty Corp. offers a yield of 7.63% to investors and pays a quarterly dividend of $0.26 per share. Douglas Emmett, Inc. pays 781.89% of its earnings as a dividend. SL Green Realty Corp. pays out 3826.34% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Douglas Emmett, Inc. quarterly revenues are $249.4M, which are smaller than SL Green Realty Corp. quarterly revenues of $276.5M. Douglas Emmett, Inc.'s net income of -$19.8M is higher than SL Green Realty Corp.'s net income of -$103.7M. Notably, Douglas Emmett, Inc.'s price-to-earnings ratio is 113.48x while SL Green Realty Corp.'s PE ratio is 654.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Douglas Emmett, Inc. is 1.71x versus 2.77x for SL Green Realty Corp.. Usually stocks with elevated PS ratios are considered overvalued.